In response to the coronavirus disease 2019 (COVID-19) pandemic, health care providers and institutions have recommended delaying the treatment of some patients with cancer, especially during peaks of infection incidence, with the intent of reducing patient exposure to the virus and prioritizing health care resources. For patients and clinicians who may be uneasy about delaying cancer treatments during the COVID-19 pandemic, 2 new studies that analyzed data from the National Cancer Data Base (NCDB) have offered some reassurance. Both investigations—a breast cancer study published in the Journal of the American College of Surgeons (2020;231:434-447.e2. doi:10.1016/j. jamco llsurg.2020.06.021) and a prostate cancer study that appeared in JAMA Oncology (2020;6:1630-1632. doi:10.1001/jamao ncol.2020.3545)— concluded that, in many cases, delayed breast surgery and prostate radiotherapy after diagnosis will not lead to worse outcomes. Breast Cancer Study Details

中文翻译：

---

COVID-19 大流行导致的癌症治疗延迟可能不会影响结果

为应对 2019 年冠状病毒病 (COVID-19) 大流行，医疗保健提供者和机构建议推迟对某些癌症患者的治疗，尤其是在感染高峰期，目的是减少患者接触病毒并优先考虑健康护理资源。对于在 COVID-19 大流行期间可能对延迟癌症治疗感到不安的患者和临床医生，2 项分析来自国家癌症数据库 (NCDB) 数据的新研究提供了一些保证。两项调查——发表在美国外科医师学会杂志 (2020;231:434-447.e2.doi:10.1016/j.jamco llsurg.2020.06.021) 上的乳腺癌研究和发表在 JAMA 上的前列腺癌研究Oncology (2020;6:1630-1632.doi:10.1001/jamao ncol.2020.3545)——得出的结论是，在许多情况下，诊断后延迟乳房手术和前列腺放疗不会导致更糟的结果。乳腺癌研究详情